Dr Banerjee describes the need for improved risk minimization plans for marketed drugs and the relevance of appropriate prescribing, pharmacist education, and technology in improving medication safety. Because of the complexity of pharmacotherapy and our modest understanding of the risks of marketed drugs, approaches to risk minimization involving health care providers (physicians, pharmacists, and nurses) and technology, such as the Internet, could reduce threats to medication safety. These efforts are of global importance and have captured the attention of drug policy experts and regulatory agencies, particularly in the European Union, the Middle East, and the United States.
Murray MD. Pharmacists Are Key to Enhancing Benefit Risk for Medicines—Reply. Arch Intern Med. 2009;169(18):1718-1725. doi:10.1001/archinternmed.2009.346